NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

27 hedge funds and large institutions have $1.08M invested in NeuBase Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$117K
2 -$25K
3 -$14.7K
4
State Street
State Street
Massachusetts
-$12.7K
5
Northern Trust
Northern Trust
Illinois
-$10.2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$311K
2
$255K
3
$117K
4
$92.5K
5
$87.8K
6
$47.7K
7
$35.5K
8
$29.1K
9
$29K
10
$24K
11
$21.6K
12
$14.6K
13
$11K
14
$1.5K
15
$1.32K
16
$1K
17
$997
18
$868
19
$127
20
$116
21
$41
22
$39
23
$24
24
$22
25
$22